Nutritional or pharmacological activation of HCA(2) ameliorates neuroinflammation - PubMed (original) (raw)

Review

Nutritional or pharmacological activation of HCA(2) ameliorates neuroinflammation

Stefan Offermanns et al. Trends Mol Med. 2015 Apr.

Abstract

Neuroinflammation is a pathology common to many neurological diseases, including multiple sclerosis (MS) and stroke. However, therapeutic attempts to modulate neuroinflammation have proved difficult. Neuroinflammatory cells express HCA2, a receptor for the endogenous neuroprotective ketone body β-hydroxybutyrate (BHB) as well as for the drugs dimethyl fumarate (DMF) and nicotinic acid, which have established efficacy in the treatment of MS and experimental stroke, respectively. This review summarizes the evidence that HCA2 is involved in the therapeutic effects of DMF, nicotinic acid, and ketone bodies in reducing neuroinflammation. Furthermore, we discuss the mechanisms underlying the beneficial effects of HCA2 activation in neuroinflammatory diseases and the therapeutic potential of recently developed synthetic ligands of HCA2.

Keywords: G protein-coupled receptor; cerebral ischemia; experimental autoimmune encephalomyelitis; hydroxy carboxylic acid receptor; ketogenic diet; multiple sclerosis.

Copyright © 2015 Elsevier Ltd. All rights reserved.

PubMed Disclaimer

Similar articles

• The β-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages.
  Rahman M, Muhammad S, Khan MA, Chen H, Ridder DA, Müller-Fielitz H, Pokorná B, Vollbrandt T, Stölting I, Nadrowitz R, Okun JG, Offermanns S, Schwaninger M. Rahman M, et al. Nat Commun. 2014 May 21;5:3944. doi: 10.1038/ncomms4944. Nat Commun. 2014. PMID: 24845831
• The Immunometabolomic Interface Receptor Hydroxycarboxylic Acid Receptor 2 Mediates the Therapeutic Effects of Dimethyl Fumarate in Autoantibody-Induced Skin Inflammation.
  Wannick M, Assmann JC, Vielhauer JF, Offermanns S, Zillikens D, Sadik CD, Schwaninger M. Wannick M, et al. Front Immunol. 2018 Aug 14;9:1890. doi: 10.3389/fimmu.2018.01890. eCollection 2018. Front Immunol. 2018. PMID: 30154797 Free PMC article.
• Dimethyl fumarate downregulates the immune response through the HCA2/GPR109A pathway: Implications for the treatment of multiple sclerosis.
  von Glehn F, Dias-Carneiro RPC, Moraes AS, Farias AS, Silva VAPG, Oliveira FTM, Silva CEBG, de Carvalho F, Rahal E, Baecher-Allan C, Santos LMB. von Glehn F, et al. Mult Scler Relat Disord. 2018 Jul;23:46-50. doi: 10.1016/j.msard.2018.04.016. Epub 2018 Apr 25. Mult Scler Relat Disord. 2018. PMID: 29763776 Review.
• β-hydroxybutyrate and hydroxycarboxylic acid receptor 2 agonists activate the AKT, ERK and AMPK pathways, which are involved in bovine neutrophil chemotaxis.
  Carretta MD, Barría Y, Borquez K, Urra B, Rivera A, Alarcón P, Hidalgo MA, Burgos RA. Carretta MD, et al. Sci Rep. 2020 Jul 27;10(1):12491. doi: 10.1038/s41598-020-69500-2. Sci Rep. 2020. PMID: 32719460 Free PMC article.
• Anti-inflammatory effects of the hydroxycarboxylic acid receptor 2.
  Graff EC, Fang H, Wanders D, Judd RL. Graff EC, et al. Metabolism. 2016 Feb;65(2):102-13. doi: 10.1016/j.metabol.2015.10.001. Epub 2015 Nov 13. Metabolism. 2016. PMID: 26773933 Review.

Cited by

• Multiple recent HCAR2 structures demonstrate a highly dynamic ligand binding and G protein activation mode.
  Shenol A, Tenente R, Lückmann M, Frimurer TM, Schwartz TW. Shenol A, et al. Nat Commun. 2024 Jun 25;15(1):5364. doi: 10.1038/s41467-024-49536-y. Nat Commun. 2024. PMID: 38918366 Free PMC article. Review.
• The Evolving Role of Monomethyl Fumarate Treatment as Pharmacotherapy for Relapsing-Remitting Multiple Sclerosis.
  Kaye AD, Lacey J, Le V, Fazal A, Boggio NA, Askins DH, Anderson L, Robinson CL, Paladini A, Mosieri CN, Kaye AM, Ahmadzadeh S, Shekoohi S, Varrassi G. Kaye AD, et al. Cureus. 2024 Apr 6;16(4):e57714. doi: 10.7759/cureus.57714. eCollection 2024 Apr. Cureus. 2024. PMID: 38711693 Free PMC article. Review.
• Ketogenic therapy towards precision medicine for brain diseases.
  Liu Y, Fan L, Yang H, Wang D, Liu R, Shan T, Xia X. Liu Y, et al. Front Nutr. 2024 Feb 21;11:1266690. doi: 10.3389/fnut.2024.1266690. eCollection 2024. Front Nutr. 2024. PMID: 38450235 Free PMC article. Review.
• Ketogenic diet and BHB rescue the fall of long-term potentiation in an Alzheimer's mouse model and stimulates synaptic plasticity pathway enzymes.
  Di Lucente J, Persico G, Zhou Z, Jin LW, Ramsey JJ, Rutkowsky JM, Montgomery CM, Tomilov A, Kim K, Giorgio M, Maezawa I, Cortopassi GA. Di Lucente J, et al. Commun Biol. 2024 Feb 16;7(1):195. doi: 10.1038/s42003-024-05860-z. Commun Biol. 2024. PMID: 38366025 Free PMC article.
• Metabolite-sensing GPCRs controlling interactions between adipose tissue and inflammation.
  Duncan EM, Vita L, Dibnah B, Hudson BD. Duncan EM, et al. Front Endocrinol (Lausanne). 2023 Jul 6;14:1197102. doi: 10.3389/fendo.2023.1197102. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37484963 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • ClinicalKey
  • Elsevier Science

• Other Literature Sources

  • H1 Connect
  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • Guide to Pharmacology